Children

A collaborative study from the Center for Injury Research and Prevention (CIRP) and the Center for Autism Research (CAR) at Children’s Hospital of Philadelphia (CHOP) found that only 8% of pediatric healthcare and behavioral service providers feel prepared to assess whether their autistic patients are ready to drive. These findings, recently published in the Journal
0 Comments
With the last monthly Child Tax Credit payment of the year set for distribution on Dec. 15, new research offers insights into which low-income families are still not receiving their checks. The reasons vary from another parent claiming the credit to processing issues and unknown reasons that indicate barriers in the tax filing process. In
0 Comments
Researchers from four academic neurosurgical centers in Japan found that the parietooccipital fissure, which divides the temporal, occipital, and parietal lobes of the brain, acts as an obstacle that may result in less invasion of posterior medial temporal gliomas toward the occipital lobe. Detailed findings, including images obtained with magnetic resonance and diffusion tensor imaging
0 Comments
Childhood trauma may increase the chance of young people experiencing psychotic symptoms when using cannabis, University of Queensland research has found. UQ School of Psychology Honorary Fellow, Dr Molly Carlyle, said childhood trauma was a major factor in cannabis use problems and psychosis in young people. “Our research found cannabis use was associated with more
0 Comments
A new bed tower at Duke University Hospital has now fully opened, with pediatric patients and their families moving into new rooms on four floors over the weekend. The move-in culminates years of planning and construction of the 11-floor Duke Central Tower, which was designed to provide larger, private patient rooms that accommodate technologically advanced
0 Comments
Diagnosis of community acquired pneumonia in children usually involves x-rays, despite recommendations to limit their use by professional societies. In efforts to reduce radiation exposure from x-rays in children and reinforce guideline compliance, researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues developed a simple diagnostic model that accurately predicts whether
0 Comments
Northwestern investigators have discovered the molecular signature of a subset of dopaminergic neurons with an increased vulnerability to degeneration. The findings shed light on the mechanisms at play within a small subsection of the brain’s substantia nigra, called the pars compacta, which contribute to the development of Parkinson’s disease and may help identify novel therapeutic
0 Comments
An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that the same natural killer cells also can help some children and young
0 Comments
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11. The findings of the international multicenter Liberty Asthma VOYAGE trial, reported
0 Comments
For many emerging adults, the period between 18 and 25 years of age marks a stage of life to explore what matters to them and assume new legal rights and responsibilities, including their own private health information and medical decision-making. But this transition to independence can create sticky family dynamics, especially when emerging adults remain
0 Comments
Adapted with permission from the American Heart Association. Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association’s flagship journal Circulation. Myocarditis is a rare but serious condition that
0 Comments
Octapharma USA today announced the U.S. Food & Drug Administration (FDA) has approved cutaquig® [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig® for adults with PI. “The FDA approval provides physicians and families with more treatment options
0 Comments
Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association’s flagship journal Circulation. Myocarditis is a rare but serious condition that causes inflammation of the heart muscle. It can
0 Comments
In a recent study, researchers from France evaluated the association between maternal morbidities and coronavirus disease 2019 (COVID-19). In this retrospective analysis, the researchers found that as compared to pregnant women without COVID-19, there was an increased frequency of pregnant women with maternal morbidities and the diagnosis of COVID-19. This PLOS Medicine study is the
0 Comments
This first-in-human study of golodirsen showed its long-term safety and biologic activity in patients with Duchenne Muscular Dystrophy (DMD). The approved exon-skipping therapy is designed to enable the production of functional dystrophin proteins, as described in the peer-reviewed journal Nucleic Acid Therapeutics. Golodirsen was tested in ambulatory patients with exon 53 skip amenable DMD. They
0 Comments